People in the News

Premium

David Matthews has been named chief financial officer at Med BioGene, the Vancouver, BC-based firm said last week.

Matthews served previously as a director for BMO Capital, a subsidiary of the Bank of Montreal. Prior to that, he was the managing director of Aspreva Pharmaceuticals, the European subsidiary of Aspreva Pharmaceuticals, now Galenica Group. Matthews also was CFO of StressGen Biotechnologies and Allelix Biopharmaceuticals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.